Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A FREEDMAN

Showing results (861-870 of 916) with videos related to

Pageof 92
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
JAMA Oncology|January 28, 2021
Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus StatementRachel A Freedman, Christina A Minami, Eric P Winer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Palliative careMichael H Levy, Michael D Adolph, Anthony Back, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
Cancer Research|March 24, 2025
Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational ProfilesMarco Matejcic, Jamie K Teer, Hannah J Hoehn, et al.
Military Medicine|November 26, 2020
The Military Orthopedics Tracking Injuries and Outcomes Network: A Solution for Improving Musculoskeletal Care in the Military Health SystemTimothy C Mauntel, Matthew S Tenan, Brett A Freedman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyPatrick A Brown, Bijal Shah, Anjali Advani, et al.
JCO Precision Oncology|September 14, 2020
Identifying <i>ERBB2</i> Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy TrialsPedro Exman, Ana C Garrido-Castro, Melissa E Hughes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022R A Freedman, H M Heiling, T Li, et al.
Pageof 92

Showing results (861-870 of 916) with videos related to

Sort By:
Pageof 92
Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
JAMA Oncology|January 28, 2021
Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus StatementRachel A Freedman, Christina A Minami, Eric P Winer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 12, 2012
Palliative careMichael H Levy, Michael D Adolph, Anthony Back, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2019
AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyErin Reid, Gita Suneja, Richard F Ambinder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
Cancer Research|March 24, 2025
Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational ProfilesMarco Matejcic, Jamie K Teer, Hannah J Hoehn, et al.
Military Medicine|November 26, 2020
The Military Orthopedics Tracking Injuries and Outcomes Network: A Solution for Improving Musculoskeletal Care in the Military Health SystemTimothy C Mauntel, Matthew S Tenan, Brett A Freedman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyPatrick A Brown, Bijal Shah, Anjali Advani, et al.
JCO Precision Oncology|September 14, 2020
Identifying <i>ERBB2</i> Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy TrialsPedro Exman, Ana C Garrido-Castro, Melissa E Hughes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 2024
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022R A Freedman, H M Heiling, T Li, et al.
Pageof 92